Andreas Katopodis | Chief Executive Officer
Anaveon | Switzerland

Andreas Katopodis, Chief Executive Officer, Anaveon

Andreas is co-founded Anaveon in April 2018, and previously was the Director of Autoimmunity, Transplantation & Inflammation, Novartis Institutes of  Biomedical Research, Basel Big Pharma experience in the discovery and development of immunomodulating drugs (26 years) Extensive BD&L experience, supported and closed multiple deals between pharma and start-ups Faculty at the Georgia Institute of Technology (5 years)


Oct 31st Day 3 @ 12:20

Next generation cancer immunotherapy using IL-2/antibody complexes

last published: 19/Sep/19 13:06 GMT

back to speakers

Sign Up for Event Updates